- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Top Stock Picks from Analysts
Global Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
826
Companies which are more than 50% undervalued based on analyst price target.
826 companies
C4 Therapeutics
Market Cap: US$104.4m
A clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins.
CCCC
US$1.58
7D
-2.5%
1Y
-74.4%
BioPorto
Market Cap: DKK 690.2m
An in-vitro diagnostics company, focuses on developing biomarker tests to help clinicians detect the onset of disease states for management and therapies in Europe, North America, Asia, and internationally.
BIOPOR
DKK 1.52
7D
-4.5%
1Y
-20.1%
Coya Therapeutics
Market Cap: US$101.2m
A clinical-stage biotechnology company, develops proprietary therapies to enhance the function of regulatory T cells (Tregs).
COYA
US$6.14
7D
-4.2%
1Y
-24.0%
Lineage Cell Therapeutics
Market Cap: US$100.5m
A clinical-stage biotechnology company, develops novel cell therapies for neurological and ophthalmic conditions in the United States and internationally.
LCTX
US$0.48
7D
4.5%
1Y
-56.0%
Contineum Therapeutics
Market Cap: US$100.1m
A clinical stage biopharmaceutical company, engages in developing of small molecules different therapies for neuroscience, inflammation, and immunology indications with high unmet need in the United States.
CTNM
US$3.83
7D
-3.5%
1Y
-75.3%
RAPT Therapeutics
Market Cap: US$99.7m
Operates as a clinical-stage immunology-based biopharmaceutical company that focuses on the discovery, development, and commercialization of oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases in the United States.
RAPT
US$0.88
7D
-3.8%
1Y
-80.0%
TCM Biotech International
Market Cap: NT$3.0b
A biotech company, engages in the research and development of drugs for the prevention and treatment of liver diseases.
4169
NT$50.90
7D
-0.6%
1Y
-7.8%
Aroa Biosurgery
Market Cap: AU$153.5m
Develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally.
ARX
AU$0.46
7D
2.2%
1Y
-8.0%
Diamyd Medical
Market Cap: SEK 961.2m
Develops precision medicine therapies for the treatment of autoimmune diabetes.
DMYD B
SEK 9.20
7D
-1.8%
1Y
-21.4%
Entera Bio
Market Cap: US$97.7m
A clinical stage company, focuses on developing oral peptide or protein replacement therapies for unmet medical needs.
ENTX
US$2.15
7D
-6.1%
1Y
-8.1%
Immunic
Market Cap: US$96.8m
A biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany.
IMUX
US$0.99
7D
-11.9%
1Y
-21.4%
Vaxart
Market Cap: US$95.6m
A clinical-stage biotechnology company, discovers and develops oral recombinant protein vaccines based on its vector-adjuvant-antigen standardized technology proprietary oral vaccine platform in the United States.
VXRT
US$0.41
7D
-2.4%
1Y
-50.6%
MaaT Pharma
Market Cap: €85.9m
A late-stage clinical company, engages in the development of gut microbiome-driven therapies to modulate the immune system and improve cancer survival.
MAAT
€5.34
7D
-4.6%
1Y
-42.8%
OptiNose
Market Cap: US$95.1m
A specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists.
OPTN
US$9.42
7D
0%
1Y
-46.3%
Cardiol Therapeutics
Market Cap: CA$132.2m
A clinical-stage life sciences company, focuses on the developing of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases.
CRDL
CA$1.59
7D
0%
1Y
-47.2%
Black Diamond Therapeutics
Market Cap: US$92.9m
A clinical-stage oncology company, focuses on the discovery and development of MasterKey therapies for patients with genetically defined tumors.
BDTX
US$1.75
7D
4.8%
1Y
-70.5%
MDxHealth
Market Cap: US$92.6m
A commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally.
MDXH
US$1.83
7D
4.6%
1Y
-36.9%
Assembly Biosciences
Market Cap: US$91.8m
A biotechnology company, develops therapeutic candidates for the treatment of viral diseases worldwide.
ASMB
US$12.35
7D
-12.6%
1Y
-7.8%
Kyverna Therapeutics
Market Cap: US$91.2m
Kyverna Therapeutics, Inc., clinical-stage biopharmaceutical company, focuses on developing cell therapies for patients with autoimmune diseases.
KYTX
US$2.21
7D
3.8%
1Y
-84.9%
Nanoform Finland Oyj
Market Cap: €82.0m
Engages in the provision of nanotechnology and drug particle engineering services for the pharma and biotech industries in Europe and the United States.
NANOFH
€0.96
7D
-4.1%
1Y
-48.2%
MacroGenics
Market Cap: US$90.2m
A clinical-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes antibody-based therapeutics to treat cancer in the United States.
MGNX
US$1.59
7D
-3.0%
1Y
-63.7%
Lexeo Therapeutics
Market Cap: US$89.3m
A clinical stage genetic medicine company, focuses on hereditary and acquired diseases with high unmet need in the United States.
LXEO
US$2.63
7D
-40.9%
1Y
-80.6%
Zentalis Pharmaceuticals
Market Cap: US$88.5m
A clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers.
ZNTL
US$1.29
7D
-5.1%
1Y
-89.0%
Nautilus Biotechnology
Market Cap: US$88.3m
A development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome.
NAUT
US$0.72
7D
5.5%
1Y
-73.5%
Ventyx Biosciences
Market Cap: US$88.2m
A clinical-stage biopharmaceutical company, develops oral therapies for patients with autoimmune, inflammatory, and neurodegenerative diseases.
VTYX
US$1.21
7D
-12.3%
1Y
-70.6%
Nykode Therapeutics
Market Cap: NOK 914.3m
A clinical-stage biopharmaceutical company, discovers and develops novel immunotherapies.
NYKD
NOK 2.80
7D
10.1%
1Y
-80.1%
Elicio Therapeutics
Market Cap: US$87.5m
A clinical-stage biotechnology company, develops immunotherapies for the treatment of cancer.
ELTX
US$5.52
7D
2.0%
1Y
-42.8%
Transgene
Market Cap: €78.1m
A biotechnology company, designs and develops therapeutic vaccines and oncolytic viruses for the treatment of cancer in France.
TNG
€0.59
7D
-3.0%
1Y
-54.8%
Pliant Therapeutics
Market Cap: US$86.6m
A biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases.
PLRX
US$1.47
7D
-7.5%
1Y
-89.2%
Instil Bio
Market Cap: US$86.3m
A clinical-stage biopharmaceutical company, focuses on developing a pipeline of novel therapies.
TIL
US$13.68
7D
-2.6%
1Y
15.9%
Trajan Group Holdings
Market Cap: AU$134.1m
Develops, manufactures, sells, and distributes analytical and life science products and devices in Australia, New Zealand, Malaysia, Japan, the United States, Europe, the Middle East, Africa, and India.
TRJ
AU$0.88
7D
3.6%
1Y
-3.8%
Champions Oncology
Market Cap: US$85.3m
A technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States.
CSBR
US$6.00
7D
-0.3%
1Y
26.8%
Elutia
Market Cap: US$85.0m
A commercial-stage company, develops and commercializes drug-eluting biologics products for neurostimulation and breast reconstruction in the United States.
ELUT
US$1.82
7D
-4.2%
1Y
-46.8%
Senti Biosciences
Market Cap: US$84.8m
Operates as a clinical-stage biotechnology company that develops next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients with incurable diseases.
SNTI
US$3.26
7D
-0.6%
1Y
-9.9%
Anixa Biosciences
Market Cap: US$84.0m
A biotechnology company, develops therapies and vaccines that are focused on critical unmet needs in oncology.
ANIX
US$2.66
7D
-5.3%
1Y
-10.4%
OncoCyte
Market Cap: US$82.1m
Operates as a precision diagnostics company in the United States and internationally.
OCX
US$2.81
7D
-3.8%
1Y
-2.6%